← FDA Drug Approvals (Drugs@FDA)

LORATADINE

NDA · New Drug Application · Sponsor: SUN PHARMA CANADA · Approved 2005-10-04

Drug application

FDA Application #

NDA021734

Application type

New Drug Application

Brand name

LORATADINE

Generic name

Loratadine

Active ingredients

LORATADINE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Discontinued

Sponsor

SUN PHARMA CANADA

First approval

2005-10-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown